GANESH BENZOPLAST LTD.

Ganesh Benzoplast Ltd announced that the National Company Law Appellate Tribunal (NCLAT) has dismissed an appeal filed by Progfin Private Limited seeking to initiate corporate insolvency resolution process against the company. The appeal was related to alleged default in repayment of credit facilities extended to Ganesh Benzoplast's wholly owned subsidiary, GBL Chemical Limited, for which the company had issued a corporate guarantee. The NCLAT order dated June 30, 2026, upholds the earlier decision of the National Company Law Tribunal (NCLT) which had also dismissed Progfin's petition. The company has disclosed the NCLAT order after receiving its certified true copy.

Ganesh Benzoplast Ltd has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from July 01, 2026, and will remain in effect until 48 hours after the Board of Directors approves and files the un-audited financial results for the quarter ending June 30, 2026. All connected and designated persons are advised against trading in the company's securities during this period to comply with SEBI (Prohibition of Insider Trading) Regulations, 2015. The specific date for the Board meeting to consider these financial results will be communicated separately.

Ganesh Benzoplast Limited submitted its Regulation 32 Statement for the quarter ended March 31, 2026, regarding the utilization of funds raised through preferential issues. The company confirmed no deviation or variation in the use of proceeds from a preferential issue dated March 1, 2024, which raised ₹32.40 crores. However, for another preferential issue dated January 12, 2024, which raised ₹30.35 crores, there was a deviation. This deviation was due to a change in the objects of the issue, approved by shareholders on September 25, 2025. The original object for this issue was LPG business expansion and general corporate requirements, which was modified to include infrastructure for handling liquids/gases, broader business expansion, capital expenditure, and working capital. As of March 31, 2026, ₹22.91 crores from this ₹30.35 crore issue have been utilized.

Ganesh Benzoplast Ltd's Board of Directors approved the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. They also appointed M/s S.K Agalwal & Associates as Cost Auditors and M/s. V K Baheti & Co. as Internal Auditors. The company is initiating the process to form a wholly-owned subsidiary in Singapore to explore business opportunities and better serve customers in the region.

Ganesh Benzoplast Ltd's Board of Directors approved the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. They also appointed M/s S.K Agalwal & Associates as Cost Auditors and M/s. V K Baheti & Co. as Internal Auditors. The company is initiating the process to form a wholly-owned subsidiary in Singapore to explore business opportunities and better serve customers in the region.

Anil Kumar Dedhia sold 8,50,000 shares of Ganesh Benzoplast Limited, representing 1.18% of the total share capital, via open market transaction. This sale reduces his holding from 4.63% to 3.45%. Consequently, the total shareholding of Anil Kumar Dedhia, Sandhya Anil Dedhia, Anil V Dedhia (HUF), and Vasanji Shamji Dedhia (HUF) collectively decreased from 5.56% to 4.38%. The transaction was carried out under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ganesh Benzoplast Ltd has scheduled a Board of Directors meeting on May 27, 2026, to consider and approve the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. The trading window for dealing in the company's equity shares has been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of results.

Anil Kumar Dedhia has disclosed the sale of 150,000 equity shares of Ganesh Benzoplast Limited through open market transactions on April 29, 2026. Prior to this sale, Dedhia held 3,486,000 shares, representing 4.84% of the company's total voting capital. Following the transaction, his shareholding has decreased to 3,336,000 shares, equivalent to 4.63%. This disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Dedhia is not part of the promoter group.

Ganesh Benzoplast Ltd has announced the closure of its trading window for dealing in securities. The closure will be in effect from April 01, 2026 until 48 hours after the audited financial results for the quarter and year ending on March 31, 2026 are approved by the Board of Directors and filed with stock exchanges. The date of the Board meeting to consider the financial results will be intimated separately.

According to a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, Anil Kumar Goel and Seema Goel have acquired shares in Ganesh Benzoplast Limited. The total shares acquired by the Goels amount to 28,00,000, which is 3.89% of the total share/voting capital. This acquisition also includes warrants and convertible securities. The total equity share capital and total voting capital of the company remains the same at Rs. 7,19,89,421 consisting of 7,19,89,421 equity shares of face value of Rs. 1 (one) each fully paid, both before and after the acquisition.